DexCom
DXCM
DXCM
276 hedge funds and large institutions have $7.68B invested in DexCom in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 93 increasing their positions, 88 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 273 → 276 (+3)
6% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 88
1.87% less ownership
Funds ownership: 477.97% → 476.1% (-1.9%)
Holders
276
Holding in Top 10
5
Calls
$27.4M
Puts
$22.4M
Top Buyers
| 1 | +$138M | |
| 2 | +$69.3M | |
| 3 | +$65.2M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$41.5M |
| 5 |
Neuberger Berman Group
New York
|
+$39.4M |
Top Sellers
| 1 | -$134M | |
| 2 | -$130M | |
| 3 | -$97.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$78.4M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$74.6M |